Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study.
Cox H, Salaam-Dreyer Z, Goig GA, Nicol MP, Menardo F, Dippenaar A, Mohr-Holland E, Daniels J, Cudahy PGT, Borrell S, Reinhard M, Doetsch A, Beisel C, Reuter A, Furin J, Gagneux S, Warren RM. Cox H, et al. Among authors: warren rm. Lancet Microbe. 2021 Nov;2(11):e584-e593. doi: 10.1016/S2666-5247(21)00144-0. Lancet Microbe. 2021. PMID: 34766068 Free PMC article.
Drug resistance in Mycobacterium tuberculosis.
Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC. Johnson R, et al. Among authors: warren rm. Curr Issues Mol Biol. 2006 Jul;8(2):97-111. Curr Issues Mol Biol. 2006. PMID: 16878362 Free article. Review.
Antimicrobial resistance in tuberculosis: an international perspective.
van Helden PD, Donald PR, Victor TC, Schaaf HS, Hoal EG, Walzl G, Warren RM. van Helden PD, et al. Among authors: warren rm. Expert Rev Anti Infect Ther. 2006 Oct;4(5):759-66. doi: 10.1586/14787210.4.5.759. Expert Rev Anti Infect Ther. 2006. PMID: 17140353 Review.
Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.
Louw GE, Warren RM, Gey van Pittius NC, Leon R, Jimenez A, Hernandez-Pando R, McEvoy CR, Grobbelaar M, Murray M, van Helden PD, Victor TC. Louw GE, et al. Among authors: warren rm. Am J Respir Crit Care Med. 2011 Jul 15;184(2):269-76. doi: 10.1164/rccm.201011-1924OC. Epub 2011 Apr 21. Am J Respir Crit Care Med. 2011. PMID: 21512166 Free PMC article.
Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis.
Sirgel FA, Tait M, Warren RM, Streicher EM, Böttger EC, van Helden PD, Gey van Pittius NC, Coetzee G, Hoosain EY, Chabula-Nxiweni M, Hayes C, Victor TC, Trollip A. Sirgel FA, et al. Among authors: warren rm. Microb Drug Resist. 2012 Apr;18(2):193-7. doi: 10.1089/mdr.2011.0063. Epub 2011 Jul 6. Microb Drug Resist. 2012. PMID: 21732736 Free article.
Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
Streicher EM, Müller B, Chihota V, Mlambo C, Tait M, Pillay M, Trollip A, Hoek KG, Sirgel FA, Gey van Pittius NC, van Helden PD, Victor TC, Warren RM. Streicher EM, et al. Among authors: warren rm. Infect Genet Evol. 2012 Jun;12(4):686-94. doi: 10.1016/j.meegid.2011.07.019. Epub 2011 Aug 4. Infect Genet Evol. 2012. PMID: 21839855 Review.
476 results